Medical Care

Global Drug of Abuse Screening Market Research Report 2025

The global market for Drug of Abuse Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse Screening.
The Drug of Abuse Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug of Abuse Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug of Abuse Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories, Inc.
Thermo Fisher Scientific
LabCorp (Laboratory Corporation of America)
Psychemedics Corporation
Sonic Healthcare
Bio-Rad Laboratories
Quest Diagnostics
Randox Laboratories
F. Hoffman-La Roche
Segment by Type
On-Site Screening
Laboratory-Based Screening
Segment by Application
Medical
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug of Abuse Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 On-Site Screening
1.2.3 Laboratory-Based Screening
1.3 Market by Application
1.3.1 Global Drug of Abuse Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse Screening Market Perspective (2020-2031)
2.2 Global Drug of Abuse Screening Growth Trends by Region
2.2.1 Global Drug of Abuse Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug of Abuse Screening Historic Market Size by Region (2020-2025)
2.2.3 Drug of Abuse Screening Forecasted Market Size by Region (2026-2031)
2.3 Drug of Abuse Screening Market Dynamics
2.3.1 Drug of Abuse Screening Industry Trends
2.3.2 Drug of Abuse Screening Market Drivers
2.3.3 Drug of Abuse Screening Market Challenges
2.3.4 Drug of Abuse Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug of Abuse Screening Players by Revenue
3.1.1 Global Top Drug of Abuse Screening Players by Revenue (2020-2025)
3.1.2 Global Drug of Abuse Screening Revenue Market Share by Players (2020-2025)
3.2 Global Drug of Abuse Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug of Abuse Screening Revenue
3.4 Global Drug of Abuse Screening Market Concentration Ratio
3.4.1 Global Drug of Abuse Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse Screening Revenue in 2024
3.5 Global Key Players of Drug of Abuse Screening Head office and Area Served
3.6 Global Key Players of Drug of Abuse Screening, Product and Application
3.7 Global Key Players of Drug of Abuse Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse Screening Breakdown Data by Type
4.1 Global Drug of Abuse Screening Historic Market Size by Type (2020-2025)
4.2 Global Drug of Abuse Screening Forecasted Market Size by Type (2026-2031)
5 Drug of Abuse Screening Breakdown Data by Application
5.1 Global Drug of Abuse Screening Historic Market Size by Application (2020-2025)
5.2 Global Drug of Abuse Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug of Abuse Screening Market Size (2020-2031)
6.2 North America Drug of Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug of Abuse Screening Market Size by Country (2020-2025)
6.4 North America Drug of Abuse Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug of Abuse Screening Market Size (2020-2031)
7.2 Europe Drug of Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug of Abuse Screening Market Size by Country (2020-2025)
7.4 Europe Drug of Abuse Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse Screening Market Size (2020-2031)
8.2 Asia-Pacific Drug of Abuse Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug of Abuse Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug of Abuse Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug of Abuse Screening Market Size (2020-2031)
9.2 Latin America Drug of Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug of Abuse Screening Market Size by Country (2020-2025)
9.4 Latin America Drug of Abuse Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse Screening Market Size (2020-2031)
10.2 Middle East & Africa Drug of Abuse Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug of Abuse Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug of Abuse Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Details
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Drug of Abuse Screening Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Drug of Abuse Screening Business (2020-2025)
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Drug of Abuse Screening Introduction
11.2.4 Thermo Fisher Scientific Revenue in Drug of Abuse Screening Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 LabCorp (Laboratory Corporation of America)
11.3.1 LabCorp (Laboratory Corporation of America) Company Details
11.3.2 LabCorp (Laboratory Corporation of America) Business Overview
11.3.3 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Introduction
11.3.4 LabCorp (Laboratory Corporation of America) Revenue in Drug of Abuse Screening Business (2020-2025)
11.3.5 LabCorp (Laboratory Corporation of America) Recent Development
11.4 Psychemedics Corporation
11.4.1 Psychemedics Corporation Company Details
11.4.2 Psychemedics Corporation Business Overview
11.4.3 Psychemedics Corporation Drug of Abuse Screening Introduction
11.4.4 Psychemedics Corporation Revenue in Drug of Abuse Screening Business (2020-2025)
11.4.5 Psychemedics Corporation Recent Development
11.5 Sonic Healthcare
11.5.1 Sonic Healthcare Company Details
11.5.2 Sonic Healthcare Business Overview
11.5.3 Sonic Healthcare Drug of Abuse Screening Introduction
11.5.4 Sonic Healthcare Revenue in Drug of Abuse Screening Business (2020-2025)
11.5.5 Sonic Healthcare Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Drug of Abuse Screening Introduction
11.6.4 Bio-Rad Laboratories Revenue in Drug of Abuse Screening Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse Screening Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse Screening Business (2020-2025)
11.7.5 Quest Diagnostics Recent Development
11.8 Randox Laboratories
11.8.1 Randox Laboratories Company Details
11.8.2 Randox Laboratories Business Overview
11.8.3 Randox Laboratories Drug of Abuse Screening Introduction
11.8.4 Randox Laboratories Revenue in Drug of Abuse Screening Business (2020-2025)
11.8.5 Randox Laboratories Recent Development
11.9 F. Hoffman-La Roche
11.9.1 F. Hoffman-La Roche Company Details
11.9.2 F. Hoffman-La Roche Business Overview
11.9.3 F. Hoffman-La Roche Drug of Abuse Screening Introduction
11.9.4 F. Hoffman-La Roche Revenue in Drug of Abuse Screening Business (2020-2025)
11.9.5 F. Hoffman-La Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug of Abuse Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of On-Site Screening
Table 3. Key Players of Laboratory-Based Screening
Table 4. Global Drug of Abuse Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug of Abuse Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug of Abuse Screening Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug of Abuse Screening Market Share by Region (2020-2025)
Table 8. Global Drug of Abuse Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug of Abuse Screening Market Share by Region (2026-2031)
Table 10. Drug of Abuse Screening Market Trends
Table 11. Drug of Abuse Screening Market Drivers
Table 12. Drug of Abuse Screening Market Challenges
Table 13. Drug of Abuse Screening Market Restraints
Table 14. Global Drug of Abuse Screening Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug of Abuse Screening Market Share by Players (2020-2025)
Table 16. Global Top Drug of Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2024)
Table 17. Ranking of Global Top Drug of Abuse Screening Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug of Abuse Screening Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug of Abuse Screening, Headquarters and Area Served
Table 20. Global Key Players of Drug of Abuse Screening, Product and Application
Table 21. Global Key Players of Drug of Abuse Screening, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug of Abuse Screening Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug of Abuse Screening Revenue Market Share by Type (2020-2025)
Table 25. Global Drug of Abuse Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug of Abuse Screening Revenue Market Share by Type (2026-2031)
Table 27. Global Drug of Abuse Screening Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug of Abuse Screening Revenue Market Share by Application (2020-2025)
Table 29. Global Drug of Abuse Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug of Abuse Screening Revenue Market Share by Application (2026-2031)
Table 31. North America Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug of Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug of Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug of Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug of Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug of Abuse Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug of Abuse Screening Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug of Abuse Screening Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug of Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug of Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug of Abuse Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug of Abuse Screening Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug of Abuse Screening Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories, Inc. Company Details
Table 47. Abbott Laboratories, Inc. Business Overview
Table 48. Abbott Laboratories, Inc. Drug of Abuse Screening Product
Table 49. Abbott Laboratories, Inc. Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories, Inc. Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Drug of Abuse Screening Product
Table 54. Thermo Fisher Scientific Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. LabCorp (Laboratory Corporation of America) Company Details
Table 57. LabCorp (Laboratory Corporation of America) Business Overview
Table 58. LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Product
Table 59. LabCorp (Laboratory Corporation of America) Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 60. LabCorp (Laboratory Corporation of America) Recent Development
Table 61. Psychemedics Corporation Company Details
Table 62. Psychemedics Corporation Business Overview
Table 63. Psychemedics Corporation Drug of Abuse Screening Product
Table 64. Psychemedics Corporation Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 65. Psychemedics Corporation Recent Development
Table 66. Sonic Healthcare Company Details
Table 67. Sonic Healthcare Business Overview
Table 68. Sonic Healthcare Drug of Abuse Screening Product
Table 69. Sonic Healthcare Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 70. Sonic Healthcare Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Drug of Abuse Screening Product
Table 74. Bio-Rad Laboratories Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Quest Diagnostics Company Details
Table 77. Quest Diagnostics Business Overview
Table 78. Quest Diagnostics Drug of Abuse Screening Product
Table 79. Quest Diagnostics Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 80. Quest Diagnostics Recent Development
Table 81. Randox Laboratories Company Details
Table 82. Randox Laboratories Business Overview
Table 83. Randox Laboratories Drug of Abuse Screening Product
Table 84. Randox Laboratories Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 85. Randox Laboratories Recent Development
Table 86. F. Hoffman-La Roche Company Details
Table 87. F. Hoffman-La Roche Business Overview
Table 88. F. Hoffman-La Roche Drug of Abuse Screening Product
Table 89. F. Hoffman-La Roche Revenue in Drug of Abuse Screening Business (2020-2025) & (US$ Million)
Table 90. F. Hoffman-La Roche Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report


List of Figures
Figure 1. Drug of Abuse Screening Picture
Figure 2. Global Drug of Abuse Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug of Abuse Screening Market Share by Type: 2024 VS 2031
Figure 4. On-Site Screening Features
Figure 5. Laboratory-Based Screening Features
Figure 6. Global Drug of Abuse Screening Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug of Abuse Screening Market Share by Application: 2024 VS 2031
Figure 8. Medical Case Studies
Figure 9. Research Case Studies
Figure 10. Drug of Abuse Screening Report Years Considered
Figure 11. Global Drug of Abuse Screening Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Drug of Abuse Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug of Abuse Screening Market Share by Region: 2024 VS 2031
Figure 14. Global Drug of Abuse Screening Market Share by Players in 2024
Figure 15. Global Top Drug of Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Drug of Abuse Screening Revenue in 2024
Figure 17. North America Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Drug of Abuse Screening Market Share by Country (2020-2031)
Figure 19. United States Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drug of Abuse Screening Market Share by Country (2020-2031)
Figure 23. Germany Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drug of Abuse Screening Market Share by Region (2020-2031)
Figure 31. China Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drug of Abuse Screening Market Share by Country (2020-2031)
Figure 39. Mexico Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drug of Abuse Screening Market Share by Country (2020-2031)
Figure 43. Turkey Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Drug of Abuse Screening Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Abbott Laboratories, Inc. Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 48. LabCorp (Laboratory Corporation of America) Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 49. Psychemedics Corporation Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 50. Sonic Healthcare Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 52. Quest Diagnostics Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 53. Randox Laboratories Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 54. F. Hoffman-La Roche Revenue Growth Rate in Drug of Abuse Screening Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies